RenovoRx Inc — Cash Flow (NASDAQ:RNXT) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 5.92 M8.81 M10.26 M9.13 M 10.38 M Cash from investing activities 15 K2.03 M2.03 M12 K 14 K Cash from financing activities 19.33 M42 K5.01 M15.12 M 10.88 M Free cash flow 5.92 M8.81 M10.26 M9.11 M 10.37 M

Notizie

Jones Trading avvia copertura su RenovoRx con rating Buy

Jones Trading initiates coverage on RenovoRx stock with Buy rating

Ramtin Agah, direttore medico di RenovoRx, acquista azioni per $9975

Agah Ramtin, chief medical officer at RenovoRx, buys $9975 in shares

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Abivax (NASDAQ:ABVX), Rich Sparkle Holdings (NASDAQ:ANPA)

Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Acrivon Therapeutics (NASDAQ:ACRV), AZZ (NYSE:AZZ)

Shaun Bagai acquista azioni RenovoRx (RNXT) per un valore di $4506

Shaun Bagai buys RenovoRx (RNXT) shares worth $4506

RenovoRx, Inc. (RNXT) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

Agah Ramtin, direttore medico di RenovoRx, acquista azioni RNXT per $9.600

Agah Ramtin, RenovoRx chief medical officer, buys $9,600 in RNXT

Trascrizione della relazione sugli utili: i risultati del terzo trimestre 2025 di RenovoRx mostrano un calo dei ricavi